These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 3934745

  • 1. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance.
    Wiman B, Chmielewska J.
    Scand J Clin Lab Invest Suppl; 1985; 177():43-7. PubMed ID: 3934745
    [Abstract] [Full Text] [Related]

  • 2. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK, Tran-Thang C, Bachmann F.
    Thromb Haemost; 1986 Feb 28; 55(1):65-9. PubMed ID: 3085266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
    Urdén G, Johansson U, Chmielewska J, Brandt J, Wiman B.
    Thromb Haemost; 1986 Jun 30; 55(3):383-7. PubMed ID: 3092395
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
    Huisman LG, van Griensven JM, Kluft C.
    Thromb Haemost; 1995 Mar 30; 73(3):466-71. PubMed ID: 7667830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV, Fuchs HE, Doman KA, Petruska DB, Berger H.
    Arch Intern Med; 1986 Jan 30; 146(1):188-91. PubMed ID: 2935105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
    Kuo BS, Bjornsson TD.
    Anal Biochem; 1993 Feb 15; 209(1):70-8. PubMed ID: 8465964
    [Abstract] [Full Text] [Related]

  • 11. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 15; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Verheijen JH, Chang GT, Kluft C.
    Thromb Haemost; 1984 Jul 29; 51(3):392-5. PubMed ID: 6437006
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M.
    Hokkaido Igaku Zasshi; 1985 Nov 29; 60(6):834-47. PubMed ID: 4085966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 29; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ, Shiba E, Kobayashi T, Yayoi E, Furukawa J, Takatsuka Y, Shin E, Koyama H, Inaji H, Takai S.
    Clin Cancer Res; 1998 Jan 29; 4(1):177-82. PubMed ID: 9516968
    [Abstract] [Full Text] [Related]

  • 20. Construction, expression and the characterization of t-PA mutants with increased plasma half-life and resistance to inhibition by PAI-1.
    Liu S, Huang P, Huang C.
    Chin J Biotechnol; 1995 Jan 29; 11(1):17-25. PubMed ID: 7548767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.